Pfizer/BioNTech, Moderna COVID vaccines backed for full approval in EU by EMA panel

A committee of the European Medicines Agency (EMA) recommended converting the conditional marketing authorizations (CMA) of Pfizer (NYSE:PFE) and BioNTech's (NASDAQ:BNTX) Comirnaty and Moderna's (NASDAQ:MRNA) Spikevax COVID-19 vaccines into standard marketing authorizations.